What’s Intrexon Corporation (NASDAQ:XON) Upside After This Short Interest Decrease?

Intrexon Corporation (NASDAQ:XON) Logo

Investors sentiment increased to 1.5 in Q1 2019. Its up 0.48, from 1.02 in 2018Q4. It increased, as 18 investors sold Intrexon Corporation shares while 28 reduced holdings. 24 funds opened positions while 45 raised stakes. 121.18 million shares or 4.88% more from 115.54 million shares in 2018Q4 were reported.
10,507 are owned by Redmond Asset Mngmt Ltd Com. Cacti Asset Management Limited Liability Corp invested in 0% or 7,500 shares. State Of Wisconsin Board invested in 107,500 shares or 0% of the stock. Wells Fargo & Communications Mn reported 171,680 shares or 0% of all its holdings. Jump Trading Limited Liability Company reported 0.04% of its portfolio in Intrexon Corporation (NASDAQ:XON). First Republic Investment Mgmt holds 36,000 shares. Price T Rowe Associate Md has invested 0% in Intrexon Corporation (NASDAQ:XON). Amalgamated Comml Bank holds 0% or 11,075 shares. Susquehanna Ltd Liability Partnership accumulated 87,540 shares or 0% of the stock. Stifel holds 0% or 23,329 shares in its portfolio. Engineers Gate Manager Limited Partnership stated it has 14,600 shares. Advisory Services Network holds 500 shares or 0% of its portfolio. Sumitomo Mitsui Hldgs Incorporated holds 0.01% or 1.13M shares. 11.23 million were accumulated by First Trust Advsrs Limited Partnership. Carroll Financial Associate Inc reported 1,000 shares.

Since May 13, 2019, it had 8 buys, and 0 sales for $17.62 million activity.

The stock of Intrexon Corporation (NASDAQ:XON) registered a decrease of 5.63% in short interest. XON’s total short interest was 33.69M shares in August as published by FINRA. Its down 5.63% from 35.70 million shares, reported previously. With 2.68 million shares average volume, it will take short sellers 13 days to cover their XON’s short positions. The short interest to Intrexon Corporation’s float is 70.81%.

The stock decreased 3.31% or $0.23 during the last trading session, reaching $6.72. About 1.02 million shares traded. Intrexon Corporation (NASDAQ:XON) has declined 42.97% since August 13, 2018 and is downtrending. It has underperformed by 42.97% the S&P500.

Intrexon Corporation operates in the synthetic biology field in the United States. The company has market cap of $1.09 billion. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. It currently has negative earnings. The Company’s technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics platform.

More notable recent Intrexon Corporation (NASDAQ:XON) news were published by: Nasdaq.com which released: “Why Is Intrexon (XON) Down 34% Since Last Earnings Report? – Nasdaq” on March 30, 2019, also Finance.Yahoo.com with their article: “What Does Intrexon Corporation’s (NASDAQ:XON) Balance Sheet Tell Us About It? – Yahoo Finance” published on July 05, 2019, Seekingalpha.com published: “Intrexon Q1 miss pressures shares, down 9% after hours – Seeking Alpha” on May 09, 2019. More interesting news about Intrexon Corporation (NASDAQ:XON) were released by: Streetinsider.com and their article: “Intrexon (XON) Subsidiary Precigen Inc. Reports First Patient Dosing in Phase 1 Study of PRGN-3005 UltraCAR-T – StreetInsider.com” published on August 05, 2019 as well as Nasdaq.com‘s news article titled: “Intrexon (XON) Up 24.7% Since Last Earnings Report: Can It Continue? – Nasdaq” with publication date: June 08, 2019.

Intrexon Corporation (NASDAQ:XON) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.